I agree that this site is using cookies. You can find further informations here.
X
Suzushima, D.
45  results:
Search for persons X
?
1

Modern precipitation of hydrogenetic ferromanganese mineral..:

Usui, A. ; Hino, H. ; Suzushima, D....
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
2

A PHASE 2 TRIAL OF CHOP WITH ANTI‐CCR4 ANTIBODY MOGAMULIZUM..:

Utsunomiya, A. ; Kusumoto, S. ; Choi, I....
Hematological Oncology.  41 (2023)  S2 - p. 194-195 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Prospective comparison of 5- and 7-day administration of az..:

Miyazaki, Yasushi ; Kiguchi, Toru ; Sato, Shinya...
International Journal of Hematology.  116 (2022)  2 - p. 228-238 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Quantitatively immunological characterization of mogamulizu..:

Ito, Asahi ; Suzuki, Yui ; Masaki, Ayako...
Journal of Cutaneous Immunology and Allergy.  2 (2019)  4 - p. 102-107 , 2019
Link: https://doi.org/10.1002/..
 
?
5

Systemic Lupus Erythematosus-associated Acute Acalculous Ch..:

Kudo, Noritaka ; Takaoka, Hirokazu ; Shimomura, Taizo..
Internal Medicine.  58 (2019)  19 - p. 2879-2885 , 2019
Link: https://doi.org/10.2169/..
 
?
6

TUBB1 dysfunction in inherited thrombocytopenia causes geno..:

Matsumura, Takayoshi ; Nakamura‐Ishizu, Ayako ; Takaoka, Kensuke...
British Journal of Haematology.  185 (2019)  5 - p. 888-902 , 2019
Link: https://doi.org/10.1111/..
 
?
7

Follow‐up of a randomised phase II study of chemotherapy al..:

Ishida, Takashi ; Jo, Tatsuro ; Takemoto, Shigeki...
British Journal of Haematology.  184 (2018)  3 - p. 479-483 , 2018
Link: https://doi.org/10.1111/..
 
?
8

Prognostic Analysis According to the 2017 ELN Risk Stratifi..:

Harada, Yasuhiko ; Nagata, Yasunobu ; Kihara, Rika...
Clinical Lymphoma Myeloma and Leukemia.  18 (2018)  - p. S196 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Clinical significance of ASXL2 and ZBTB7A mutations and C-t..:

Kawashima, Naomi ; Akashi, Akimi ; Nagata, Yasunobu...
Annals of Hematology.  98 (2018)  1 - p. 83-91 , 2018
Link: https://doi.org/10.1007/..
 
?
10

Prognostic analysis according to the 2017 ELN risk stratifi..:

Harada, Yasuhiko ; Nagata, Yasunobu ; Kihara, Rika...
Leukemia Research.  66 (2018)  - p. 20-27 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Galectin-9 as a Predictive Marker for the Onset of Immune-R..:

Mohammed, Tareg Omer ; Chagan-Yasutan, Haorile ; Ashino, Yugo...
The Tohoku Journal of Experimental Medicine.  241 (2017)  3 - p. 201-208 , 2017
Link: https://doi.org/10.1620/..
 
?
12

Comparison of clinicopathological characteristics between T..:

Kawamoto, Keisuke ; Miyoshi, Hiroaki ; Yanagida, Eriko...
European Journal of Haematology.  98 (2017)  5 - p. 459-466 , 2017
Link: https://doi.org/10.1111/..
 
?
13

Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: ..:

Ishida, Takashi ; Utsunomiya, Atae ; Jo, Tatsuro...
Cancer Science.  108 (2017)  10 - p. 2022-2029 , 2017
Link: https://doi.org/10.1111/..
 
?
14

Deeper molecular response is a predictive factor for treatm..:

The Japan Adult Leukemia Study Group ; Takahashi, Naoto ; Tauchi, Tetsuzo...
International Journal of Hematology.  107 (2017)  2 - p. 185-193 , 2017
Link: https://doi.org/10.1007/..
 
?
15

Enhancement of anti-STLV-1/HTLV-1 immune responses through ..:

Sugata, Kenji ; Yasunaga, Jun-ichirou ; Miura, Michi...
Scientific Reports.  6 (2016)  1 - p. , 2016
Link: https://doi.org/10.1038/..
 
1-15